Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

13.49
Delayed Data
As of Sep 21
 -0.10 / -0.74%
Today’s Change
8.67
Today|||52-Week Range
14.55
+26.07%
Year-to-Date
Glaxo-Innoviva's Triple Combo Inhaler Positive in Phase III
Sep 21 / Zacks.com - Paid Partner Content
Glaxo's Triple Therapy COPD Inhaler Gets CHMP Nod in the EU
Sep 18 / Zacks.com - Paid Partner Content
Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD
Sep 19 / Zacks.com - Paid Partner Content